167 related articles for article (PubMed ID: 8755817)
1. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3).
Ma H; Hammond EH; Taylor DO; Yowell RL; Bristow MR; O'Connell JB; Renlund DG
Transplantation; 1996 Jul; 62(2):205-10. PubMed ID: 8755817
[TBL] [Abstract][Full Text] [Related]
2. Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.
O'Connell JB; Renlund DG; Hammond EH; Wittwer CT; Yowell RL; DeWitt CW; Jones KW; Gay WA; Menlove RL; Bristow MR
J Heart Lung Transplant; 1991; 10(2):217-21; discussion 221-2. PubMed ID: 1903303
[TBL] [Abstract][Full Text] [Related]
3. Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis.
Hammond EH; Wittwer CT; Greenwood J; Knape WA; Yowell RL; Menlove RL; Craven C; Renlund DG; Bristow MR; DeWitt CW
Transplantation; 1990 Nov; 50(5):776-82. PubMed ID: 2122559
[TBL] [Abstract][Full Text] [Related]
4. Use of OKT3 monoclonal antibody in the treatment of acute cardiac allograft rejection.
Klein JB; McLeish KR; Bunke CM; Chang B; Ganzel BL; Slater AD; Gray LA
Transplantation; 1988 Apr; 45(4):727-9. PubMed ID: 3282354
[TBL] [Abstract][Full Text] [Related]
5. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
[TBL] [Abstract][Full Text] [Related]
6. Fibrinoid necrosis of a temporal artery complicating the treatment of refractory cardiac allograft rejection with murine monoclonal CD3 antibody (OKT3).
Hammond EH; Watson FS; Bristow MR; O'Connell JB; Gilbert EM; Doty DB; Renlund DG
J Heart Transplant; 1990; 9(3 Pt 1):236-8. PubMed ID: 2113090
[TBL] [Abstract][Full Text] [Related]
7. Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody.
Gilbert EM; Dewitt CW; Eiswirth CC; Renlund DG; Menlove RL; Freedman LA; Herrick CM; Gay WA; Bristow MR
Am J Med; 1987 Feb; 82(2):202-6. PubMed ID: 3544838
[TBL] [Abstract][Full Text] [Related]
8. Some aspects of changed histopathologic appearance of acute rejection in cardiac allografts after prophylactic application of OKT3.
Kemnitz J; Cremer J; Schaefers HJ; Restrepo-Specht I; Haverich A; Uysal A; Heublein B; Wirth S
J Heart Lung Transplant; 1991; 10(3):366-72. PubMed ID: 1906746
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of OKT3 retreatment for refractory cardiac allograft rejection.
O'Connell JB; Renlund DG; Gay WA; DeWitt CW; Hammond EH; Yowell RL; Jones KW; Karwande SV; Doty DB; Bristow MR
Transplantation; 1989 May; 47(5):788-92. PubMed ID: 2655215
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3.
Taylor DO; Bristow MR; O'Connell JB; Ensley RD; Olsen SL; Hammond EH; Wagoner LE; Renlund DG
Transplantation; 1994 Sep; 58(6):645-9. PubMed ID: 7940682
[TBL] [Abstract][Full Text] [Related]
11. Immunologic monitoring of OKT3 induction therapy in cardiac allograft recipients.
Toyoda M; Galfayan K; Wachs K; Czer L; Jordan SC
Clin Transplant; 1995 Dec; 9(6):472-80. PubMed ID: 8645891
[TBL] [Abstract][Full Text] [Related]
12. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
13. Prevention of adverse clinical outcome by monitoring of cardiac transplant patients for murine monoclonal CD3 antibody (OKT3) sensitization.
Hammond EA; Yowell RL; Greenwood J; Hartung L; Renlund D; Wittwer C
Transplantation; 1993 May; 55(5):1061-3. PubMed ID: 8497882
[TBL] [Abstract][Full Text] [Related]
14. OKT3 treatment of cardiac allograft rejection.
Haverty TP; Sanders M; Sheahan M
J Heart Lung Transplant; 1993; 12(4):591-8. PubMed ID: 8369321
[TBL] [Abstract][Full Text] [Related]
15. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
[TBL] [Abstract][Full Text] [Related]
17. The duration of administration of monoclonal antibody OKT3 for induction immunosuppression after heart transplantation.
Aleksic I; Freimark D; Blanche C; Czer LS; Dalichau H; Valenza M; Takkenberg JJ; Trento A
Thorac Cardiovasc Surg; 1997 Aug; 45(4):190-5. PubMed ID: 9323821
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation.
van Gelder T; Balk AH; Jonkman FA; Zietse R; Zondervan P; Hesse CJ; Vaessen LM; Mochtar B; Weimar W
Transplantation; 1996 Jul; 62(1):51-5. PubMed ID: 8693545
[TBL] [Abstract][Full Text] [Related]
19. Are surveillance endomyocardial biopsies necessary during OKT3 induction therapy?
Daoud AJ; Bhat G; Schroeder TJ
Transplantation; 1997 Jul; 64(2):368-70. PubMed ID: 9256204
[TBL] [Abstract][Full Text] [Related]
20. Successful retreatment of allograft rejection with OKT3.
First MR; Schroeder TJ; Hurtubise PE; Mansour ME; Penn I; Munda R; Balistreri WF; Alexander JW; Melvin DB; Fidler JP
Transplantation; 1989 Jan; 47(1):88-91. PubMed ID: 2521410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
